[HSF] More on the Traysylol saga

Michael Firstenberg msfirst at gmail.com
Sun Oct 8 18:49:08 EDT 2006


A major problem that I have with all of this kind of stuff is the  
statistics.
A very good friend of mine (a woman no less) who was a PhD researcher  
used to say that "statistics are like a string bikini - what they  
reveal is interesting, but what they hide is....." well lets keep  
this a family show.

We are all smart people, and I would like to think of myself as not  
to shabby myself, but the whole field of medical statistics has just  
gotten out of control in how complicated it is.  Yes, I read these  
articles and usually skip over the statistics part of the methods - I  
trust (yeah, big joke) that the editorial boards are doing their  
homework and the techniques are proper - but who knows.  Now with all  
of this propensity scoring and whatever the trendy test du jour is  
combined with whatever crafty manipulation of the hypothesis, data,  
and/or conclusions (ad hoc analysis, sub-group hypothesis testing,  
non-superiority testing, yadda yadda yadda), not to mention vague  
definitions (anyone want to give a standard definition of 3+ MR?) -  
this stuff has gotten out of control.

...am I missing something here?


michael





On Oct 8, 2006, at 9:11 AM, Ani Anyanwu wrote:

> Dear Dr Levinson
>
> I am not sure statistics has much to do with this one. The  
> statistics in the NEJM Aprotinin paper to my knowledge has not been  
> a subject of criticism. The problem with Mangano's paper is one of  
> flawed methodology and not flawed statistics. Aside from the  
> methodological flaws in the paper, they make the mistake of  
> publishing a paper that uses the wrong method (retrospective study  
> rather than RCT) to assess safety profile of a drug and they  
> allowed the authors, as you said, to make inflammatory conclusions.  
> The debate about statistics, P-values etc  does not really apply to  
> this paper. The dilemmas you mention are things that should come up  
> in discussion and interpretation of data.
>
> I see no problem too with surgeons publishing in NEJM - we would  
> all rather see our landmark papers published there than in any  
> surgical journal. The problem we are dealing with is a biased  
> editorial board with their own agenda. It would be very easy for  
> them to seek a surgical review of the manuscript (and I suspect  
> they did).
>
> I do not think our cardiothoracic journals are any better - most of  
> the flaws we see in the NEJM we also see in the surgical journals  
> and certainly we see far more poorly designed, flawed methodology,  
> and 'inappropriately published' articles in our journals than are  
> in the NEJM. In our specialty journals, who you are or where you  
> work can guarantee you to get any manuscript published regardless  
> of content. The difference though is that people (including non  
> surgeons) regard NEJM as holy grail so NEJM has a greater  
> responsibility to ensure they do not mislead the public compared  
> to  specialist journals.
>
> Ani Anyanwu
>
>
> ----- Original Message -----
>   From: Mark Levinson, MD<mailto:mmlevinson at hsforum.com>
>   To: OpenHeart-L at lists.hsforum.com<mailto:OpenHeart- 
> L at lists.hsforum.com>
>   Sent: Sunday, October 08, 2006 1:45 AM
>   Subject: Re: [HSF] More on the Traysylol saga
>
>
>
>   On Oct 5, 2006, at 3:21 AM, Ben Bidstrup wrote:
>
>> The power that Journal  Editors have is such that they must be
>> answerable for their actions. ........ Now if a statistician who
>> has such an exalted post cannot indicate the weaknesses in this
>> study, then he should withdraw his paper and offer an apology, to
>> all readers of the journal, to the public and to patients who
>> suffered as a result of the non use of aprotinin. He should also be
>> joined in any action.
>
>   Ben:
>
>   I appreciate your comments.     We have discussed the role of
>   statistical consultation for each manuscript submitted to the HSF
>   journal during our Board meetings.    Although this seems like the
>   answer for  blocking papers with bad science, there are problems.
>   First of all, not all statisticians agree.    There are many tests
>   that can be applied to the same data, of which the conclusions of
>   each test may be different.    In some cases, one statistical
>   consultant will claim a test is not even valid for the data, while
>   the other insists it is the test of choice.    Who can arbitrate
>   these differences?
>
>   Then there is the consistent dilmena of what to do with a  
> statistical
>   result.    Does a p value of 0.05 mean that the study has proved
>   cause and effect?
>
>   I agree that statistical analysis is an improvement over the era
>   where there was no statistics.   However, there are misused as
>   well.   One of the problems is that now everyone intrinsically  
> trusts
>   the final conclusions of the statistical analysis.     If a p value
>   is found, then readers believe it establishes truth, and even worse
>   "cause and effect".    Some things that could not be related are
>   forced into a relationship by the presence of a statistical result.
>
>   For example, if you were to perform a study about the mortality rate
>   of intubation, you will find the hospital  mortality is higher for
>   intubated patients than non-intubated patients.       Does this mean
>   that intubation caused their deaths?    Even if multivariant  
> analysis
>   shows that intubation is still associated with a higher mortality
>   rate, this does *not* establish cause and effect.   We all know that
>   the cause of death is the disease process which ends up with
>   intubation and the tube is not the cause.       Cause and efffect is
>   only established be eliminating each variable and repeating the
>   experiment until the observation goes away.     Since this is
>   impossible in patient care situations, we utilize less perfect
>   methods initially developed in the behavioral sciences and poorly
>   adapted to our needs in surgery.
>
>   Recently there was a paper discussing the falacies of statistical
>   analysis and centering on the t-test (the most common test used in
>   reporting differences between groups).    I was amazed at how  
> limited
>   the scope of the t-test actually is.     After reading this paper, I
>   realized that almost all of the t-tests we use are based on  
> incorrect
>   methods or assumptions.       So, we are standing on soft ground  
> with
>   even the most basic statistical analysis and we must understand  
> this....
>
>
>> Readers of the HSF who feel so inclined, should express their
>> dismay at this turn of events and send an open email to the editors
>> of the Journal and to Mr David Armstrong,  
>> (David.Armstrong at wsj.com<mailto:David.Armstrong at wsj.com>)
>> the author of the article in the Wall Street Journal (Hal's
>> favourite medical source). Furthermore, you should encourage your
>> library to cancel their subscription to the NEJM. The Massachusetts
>> Medical Society should also be contacted.
>>
>
>   Personally, the main failure of the NEJM is that they published a
>   paper on a surgical subject when they are a medical journal.  They
>   are no experts in surgical sciences and should have referred the
>   author to another journal.    They are not set up to evaluate
>   articles on surgical subspecialties.      The results analyzed were
>   surgical endpoints.    I do not know who the reviewers were, but I
>   doubt any surgeon, and particularly any cardiac surgeon, reviewed
>   this paper prior to publication.    Also, whoever reviewed this  
> paper
>   exceeded the normal tolerance for personal diatribes in the
>   discussion section.       Inflammatory statements made in the
>   discussion section of the Mangano paper should have raised a flag  
> and
>   caused a secondary review, or be returned to the author for
>   deletion.       It is my opinion that if the same paper has been
>   submitted to the HSF board, it would have been severely  
> criticized or
>   rejected outright.    But the HSF has cardiothoracic surgeons on its
>   Board while the NEJM does not.    And of course Mangano chose not to
>   submit his paper to the Annals, JTCVS or another respected
>   cardiothoracic journal.   I suspect he knew that such an audience
>   would have no problem finding the weaknesses and rejecting the paper
>   apriori.
>
>   Just my opinion....
>
>
>   Mark Levinson, M.D.
>   Founder, Editor-in-Chief
>   The Heart Surgery Forum®
>   URL:   http://www.hsforum.com<http://www.hsforum.com/>
>   Email:  mmlevinson at hsforum.com<mailto:mmlevinson at hsforum.com>
>
>
>   _______________________________________________
>   OpenHeart-L mailing list
>
>   Send postings to:
>    OpenHeart-L at lists.hsforum.com<mailto:OpenHeart-L at lists.hsforum.com>
>
>   To UNSUBSCRIBE, to CHANGE email address, or to view archives:
>   http://mmp.cjp.com/mailman/listinfo/openheart-l<http:// 
> mmp.cjp.com/mailman/listinfo/openheart-l>
>
>   All messages transmitted by the OpenHeart-L are subject to the  
> policies and
>   disclaimers posted at:
>   http://www.hsforum.com/listdisclaim<http://www.hsforum.com/ 
> listdisclaim>
>   -----------------------------------------
> _______________________________________________
> OpenHeart-L mailing list
>
> Send postings to:
>  OpenHeart-L at lists.hsforum.com
>
> To UNSUBSCRIBE, to CHANGE email address, or to view archives:
> http://mmp.cjp.com/mailman/listinfo/openheart-l
>
> All messages transmitted by the OpenHeart-L are subject to the  
> policies and
> disclaimers posted at:
> http://www.hsforum.com/listdisclaim
> -----------------------------------------



More information about the OpenHeart-L mailing list